OPINION & FEATURES
Has Nice turned a corner?
A 40% rally since its June low, the possible sale of the Actimize division, and apparently successful adoption of AI, leave analysts optimistic.
IT
Cash or shares?
“Globes” examines which form of payment is preferable in an acquisition deal and discusses whether CyberArk, Mellanox, and Teva made the right M&A decisions.
Mergers & acquisitions